The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
February 10th 2025
A study found a strong link between headache disorders and suicide risk, including tension-type headaches.
October 23rd 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management
April 3, 2025
Register Now!
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies
View More
Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis
View More
Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
View More
Signaling Molecules May Limit Bone Destruction and Bone Loss from RA
September 29th 2009Researchers have discovered a new way to use the role of signaling molecules to inhibit another complex that plays a key role in the ‘turning on’ of genes “that cause the stem cell precursors of osteoclasts to mature and start eating bone,” a discovery that may lead to the formation of new rheumatoid arthritis and osteoporosis drugs.
Migraine Sufferers Better Off Staying Home than Working through the Pain
September 29th 2009Individuals who go to work with a migraine, with the thought that it is better to “endure the pain” and stay at work, are actually less productive than individuals who stay home because of a migraine, with the level of productivity while suffering from a migraine is impacted by whether the migraine is chronic or episodic, the results of two new studies show.
Excessive Bone Growth Following Trauma, Surgery Can be Stopped
September 28th 2009Using an experimental drug, Thomas Jefferson University researchers were able to prevent heterotopic ossification in animal models, giving hope that human treatments will follow for this disease affecting up to 70 percent of severely-wounded soldiers.
Stress in the Workplace may Decrease an Individual's Risk for Developing Rheumatoid Arthritis
September 10th 2009Psychosocial work stress has been previously associated with an increased risk for cardiovascular disease. New research now reveals that high work stress may actually decrease an individual's chance of developing inflammatory conditions, including rheumatoid arthritis.
Majority of Chronic Pain Patients Improperly Use Prescribed Medications
August 27th 2009An Ameritox study found that of 938,586 urine toxicology tests administered to chronic pain patients over a three-year period, 11% detected major illicit drugs and 29% had a medication in their system that the patient's doctor was likely unaware of.
FDA now Requires Stronger Warning Labels for Tumor-necrosis Factor-alpha Blockers
August 21st 2009The FDA is now requiring that stronger product warnings be included in the prescribing information of tumor necrosis factor-alpha blockers because of an increased risk of cancer in the children and adolescents who take them.
New Inhaled Therapy Provides Significant Relief from Migraine Pain
August 20th 2009Researchers from the Jefferson Headache Center have completed a multi-center, phase 3 clinical trial demonstrating that Levadex, an orally-inhaled migraine therapy, provides “significant relief” from migraine symptoms.